[Federal Register Volume 75, Number 162 (Monday, August 23, 2010)]
[Pages 51828-51829]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20857]



National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Closed 

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Heart Failure Clinical Trial.
    Date: September 3, 2010.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Youngsuk Oh, PhD, Scientific Review Officer, 
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7182, Bethesda, MD 20892-7924, 301-435-0277, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for

[[Page 51829]]

Sleep Disorders Research; 93.837, Heart and Vascular Diseases 
Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and 
Resources Research, National Institutes of Health, HHS)

    Dated: August 16, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20857 Filed 8-20-10; 8:45 am]